107 related articles for article (PubMed ID: 11970931)
1. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.
Aström E; Söderhäll S
Arch Dis Child; 2002 May; 86(5):356-64. PubMed ID: 11970931
[TBL] [Abstract][Full Text] [Related]
2. The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta.
Ipach I; Kluba T; Wolf P; Pontz B; Mittag F
Orthop Rev (Pavia); 2012 Sep; 4(3):e29. PubMed ID: 23066497
[TBL] [Abstract][Full Text] [Related]
3. Fatality owing to pulmonary hemorrhage following pamidronate disodium administration in a neonate with osteogenesis imperfecta type 2: A case report.
Nagoshi R; Amari S; Abiko Y; Sano Wada Y; Ishiguro A; Horikawa R; Ito Y
Clin Pediatr Endocrinol; 2024; 33(2):76-81. PubMed ID: 38572388
[TBL] [Abstract][Full Text] [Related]
4. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.
Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Aström E; Westgren M
Transplantation; 2005 Jun; 79(11):1607-14. PubMed ID: 15940052
[TBL] [Abstract][Full Text] [Related]
5. Optimising Health-Related Quality of Life in Children With Osteogenesis Imperfecta.
Hill CL; Ford D; Baker J
Calcif Tissue Int; 2024 May; ():. PubMed ID: 38695871
[TBL] [Abstract][Full Text] [Related]
6. Whole-Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta.
Omosule CL; Joseph D; Weiler B; Gremminger VL; Silvey S; Lafaver BN; Jeong Y; Kleiner S; Phillips CL
JBMR Plus; 2023 Jul; 7(7):e10753. PubMed ID: 37457877
[TBL] [Abstract][Full Text] [Related]
7. Exploring pain interference and self-perceived health status in children with osteogenesis imperfecta - a cross-sectional study.
Provenzano AH; Åström E; Löwing K
BMC Musculoskelet Disord; 2022 Sep; 23(1):876. PubMed ID: 36131255
[TBL] [Abstract][Full Text] [Related]
8. Uncovering the Effect of European Policy-Making Initiatives in Addressing Nutrition-Related Issues: A Systematic Literature Review and Bibliometric Analysis on Front-of-Pack Labels.
Mazzù MF; Baccelloni A; Finistauri P
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014929
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Spectrum and Molecular Basis in a Chinese Cohort of Osteogenesis Imperfecta With Mutations in Type I Collagen.
Chen P; Tan Z; Shek HT; Zhang JN; Zhou Y; Yin S; Dong Z; Xu J; Qiu A; Dong L; Gao B; To MKT
Front Genet; 2022; 13():816078. PubMed ID: 35154279
[TBL] [Abstract][Full Text] [Related]
10. Effects of Long-Term Pamidronate Treatment on Bone Density and Fracture Rate in 65 Osteogenesis Imperfecta Patients.
Yazan H; Güneş N; Akpınar E; Özyalvaç ON; Uludağ Akkaya D; Tuysuz B
Turk Arch Pediatr; 2021 Sep; 56(5):474-478. PubMed ID: 35110117
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta.
Choi Y; Hwang S; Kim GH; Lee BH; Yoo HW; Choi JH
Ann Pediatr Endocrinol Metab; 2022 Mar; 27(1):22-29. PubMed ID: 35073670
[TBL] [Abstract][Full Text] [Related]
12. Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients.
Costi S; Giani T; Orsini F; Cimaz R
Paediatr Drugs; 2022 Mar; 24(2):103-119. PubMed ID: 35013997
[TBL] [Abstract][Full Text] [Related]
13. Management of primary and secondary osteoporosis in children.
Sakka SD; Cheung MS
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20969262. PubMed ID: 33224280
[TBL] [Abstract][Full Text] [Related]
14. A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta.
Rodriguez Celin M; Kruger KM; Caudill A; Nagamani SCS; ; ; Harris GF; Smith PA
JB JS Open Access; 2020; 5(3):. PubMed ID: 32984750
[TBL] [Abstract][Full Text] [Related]
15. Oral Bisphosphonate Therapy for Osteogenesis Imperfecta: A Systematic Review and Meta-Analysis of Six Randomized Placebo-Controlled Trials.
Ying ZM; Hu B; Yan SG
Orthop Surg; 2020 Aug; 12(4):1293-1303. PubMed ID: 32589343
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta.
Malmgren B; Tsilingaridis G; Monsef-Johansson N; Qahtani ZHA; Dahllöf G; Åström E
Calcif Tissue Int; 2020 Aug; 107(2):143-150. PubMed ID: 32451573
[TBL] [Abstract][Full Text] [Related]
17. Finite element analysis of bone strength in osteogenesis imperfecta.
Varga P; Willie BM; Stephan C; Kozloff KM; Zysset PK
Bone; 2020 Apr; 133():115250. PubMed ID: 31981754
[TBL] [Abstract][Full Text] [Related]
18. Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.
Machol K; Hadley TD; Schmidt J; Cuthbertson D; Traboulsi H; Silva RC; Citron C; Khan S; Citron K; Carter E; Brookler K; Shapiro JR; Steiner RD; Byers PH; Glorieux FH; Durigova M; Smith P; Bober MB; Sutton VR; Lee BH; ; Nagamani SCS; Raggio C
Am J Med Genet A; 2020 Apr; 182(4):697-704. PubMed ID: 31876392
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bisphosphonates on Function and Mobility Among Children With Osteogenesis Imperfecta: A Systematic Review.
Constantino CS; Krzak JJ; Fial AV; Kruger KM; Rammer JR; Radmanovic K; Smith PA; Harris GF
JBMR Plus; 2019 Oct; 3(10):e10216. PubMed ID: 31687649
[TBL] [Abstract][Full Text] [Related]
20. Clinical pathologies of bone fracture modelled in zebrafish.
Tomecka MJ; Ethiraj LP; Sánchez LM; Roehl HH; Carney TJ
Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31383797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
